Ausgabe 3/2022
Inhalt (2 Artikel)
Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
J.P. Rosenheck, B.C. Keller, G. Fehringer, Z.P. Demko, S.M. Bohrade, D.J. Ross
Management of Connective Tissue Disease–related Interstitial Lung Disease
Sakir Ahmed, Rohini Handa